Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CCM NASDAQ:MGRX OTCMKTS:TNTY OTCMKTS:XCRT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCMConcord Medical Services$5.34-5.3%$5.40$3.80▼$10.77$24.79M-1.042,001 shs1,336 shsMGRXMangoceuticals$2.27+6.6%$1.80$1.32▼$7.66$22.44M2.45191,633 shs206,364 shsTNTYTrue Nature$0.20-19.8%$0.20$0.02▼$0.11$17.00M2.99785,609 shs18,501 shsXCRTXcelerate$0.02-0.6%$0.02$0.01▼$0.03$7.34M0.3116,857 shs35,500 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCMConcord Medical Services-1.04%+0.93%-1.04%-18.78%-1.11%MGRXMangoceuticals+6.57%+2.71%+33.53%+11.82%-96.37%TNTYTrue Nature0.00%+48.33%+33.40%-35.45%+47.13%XCRTXcelerate-0.59%+5.00%+7.01%-13.40%-26.32%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCMConcord Medical Services$5.34-5.3%$5.40$3.80▼$10.77$24.79M-1.042,001 shs1,336 shsMGRXMangoceuticals$2.27+6.6%$1.80$1.32▼$7.66$22.44M2.45191,633 shs206,364 shsTNTYTrue Nature$0.20-19.8%$0.20$0.02▼$0.11$17.00M2.99785,609 shs18,501 shsXCRTXcelerate$0.02-0.6%$0.02$0.01▼$0.03$7.34M0.3116,857 shs35,500 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCMConcord Medical Services-1.04%+0.93%-1.04%-18.78%-1.11%MGRXMangoceuticals+6.57%+2.71%+33.53%+11.82%-96.37%TNTYTrue Nature0.00%+48.33%+33.40%-35.45%+47.13%XCRTXcelerate-0.59%+5.00%+7.01%-13.40%-26.32%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCCMConcord Medical Services 0.00N/AN/AN/AMGRXMangoceuticals 0.00N/AN/AN/ATNTYTrue Nature 0.00N/AN/AN/AXCRTXcelerate 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCCMConcord Medical Services$52.60M0.44N/AN/A$51.05 per share0.10MGRXMangoceuticals$620K38.59N/AN/A$4.30 per share0.53TNTYTrue NatureN/AN/AN/AN/A($0.03) per shareN/AXCRTXcelerateN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCCMConcord Medical Services-$42.23MN/A0.00∞N/AN/AN/AN/AN/AMGRXMangoceuticals-$8.71M-$3.86N/A∞N/A-2,757.86%-85.01%-78.08%N/ATNTYTrue Nature-$3.88MN/A0.00∞N/AN/AN/A-13,987.90%N/AXCRTXcelerateN/AN/A0.00∞N/AN/AN/AN/AN/ALatest XCRT, CCM, MGRX, and TNTY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025MGRXMangoceuticalsN/A-$0.57N/A-$0.57N/A$0.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCCMConcord Medical ServicesN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/ATNTYTrue NatureN/AN/AN/AN/AN/AXCRTXcelerateN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCCMConcord Medical Services1.670.460.45MGRXMangoceuticalsN/A0.070.07TNTYTrue NatureN/A0.040.04XCRTXcelerateN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCCMConcord Medical ServicesN/AMGRXMangoceuticals56.72%TNTYTrue NatureN/AXCRTXcelerateN/AInsider OwnershipCompanyInsider OwnershipCCMConcord Medical Services46.50%MGRXMangoceuticals16.00%TNTYTrue Nature30.10%XCRTXcelerateN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCCMConcord Medical Services9704.34 million2.32 millionNot OptionableMGRXMangoceuticals310.54 million8.85 millionNot OptionableTNTYTrue Nature3086.57 millionN/ANot OptionableXCRTXcelerate24434.45 millionN/ANot OptionableXCRT, CCM, MGRX, and TNTY HeadlinesRecent News About These CompaniesXcelerate Inc. (XCRT) Stock Price, News, Quote & History - Yahoo FinanceJanuary 4, 2025 | finance.yahoo.comMichael F. O'SheaNovember 28, 2024 | wsj.comXcelerate, Inc. Announces FundingOctober 31, 2024 | accesswire.comAXcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare CampaignOctober 23, 2024 | accesswire.comAXcelerate, Inc. Issues Shareholder UpdateOctober 15, 2024 | accesswire.comAXcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent ApplicationsAugust 23, 2024 | finance.yahoo.comXcelerate Inc XCRTAugust 15, 2024 | morningstar.comMXcelerate, Inc. Releases Shareholder UpdateAugust 13, 2024 | accesswire.comAXcelerate, Inc. Retains Investment Bank Craft Capital Management to Provide Investment Banking and Up-Listing Advisory ServicesJune 6, 2024 | accesswire.comAXcelerate, Inc. Addresses Concerns About Recently Released Research ReportJune 4, 2024 | accesswire.comAXcelerate, Inc. Announces Change of AuditorsMay 13, 2024 | accesswire.comAXcelerate, Inc. Announces That It Has Filed Its 2023 Annual ReportApril 30, 2024 | accesswire.comAXcelerate, Inc. Announces That ESN Group, Inc. Has Gone Live on the Army & Air Force Exchange Service Online ExchangeApril 25, 2024 | accesswire.comAXcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets PresenceMarch 25, 2024 | accesswire.comAXcelerate, Inc. Announces Participation in The Microcap ConferenceJanuary 19, 2024 | finance.yahoo.comXcelerate, Inc. Announces Publication of its Two Utility Patent ApplicationsOctober 24, 2023 | finance.yahoo.comXcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange ServiceSeptember 14, 2023 | stockhouse.comXcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange ServiceSeptember 14, 2023 | finance.yahoo.comXcelerate, Inc.: Xcelerate Announces Marketing AgreementAugust 8, 2023 | finanznachrichten.deXcelerate Announces Marketing AgreementAugust 8, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeXCRT, CCM, MGRX, and TNTY Company DescriptionsConcord Medical Services NYSE:CCM$5.34 -0.30 (-5.32%) Closing price 09/12/2025 03:53 PM EasternExtended Trading$5.35 +0.01 (+0.19%) As of 09/12/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.Mangoceuticals NASDAQ:MGRX$2.27 +0.14 (+6.57%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.26 -0.02 (-0.66%) As of 09/12/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.True Nature OTCMKTS:TNTY$0.20 -0.05 (-19.84%) As of 09/12/2025True Nature Holding, Inc. focuses on engaging in compounding pharmacy activities direct to consumers, doctors, and veterinary professionals. It also focuses on the development of software applications in the healthcare arena, including telemedicine; and consideration of services offering using blockchain encryption technology for various aspects of the healthcare industry. The company is based in Atlanta, Georgia.Xcelerate OTCMKTS:XCRT$0.02 0.00 (-0.59%) As of 09/12/2025 03:02 PM EasternXcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
